TrialLipids in health and disease2020
Metabolic effects of PCSK9 inhibition with Evolocumab in subjects with elevated Lp(a).
Xiang Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
TrialLipids in health and disease2020
Xiang Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.